• Home
  • Getting Started
    • ChartMill OverviewGrowth TradersTechnical Swing Traders Long Term Investors
  • Tools
    • Stock ScreenerStock ChartsFull Screen Stock ChartsMarket MonitorSectorsEarningsAnalyzerInsider TradingUp- and Downgrades
  • Stock Market
    • Top Gainers and LosersNew 52 Week High and LowGap Up and Gap DownMost ActivePremarket MoversAfter-Hours MoversEarnings CalendarAll US stocksAll Canadian stocksAll European stocks
  • Trading Ideas
  • News
  • Blog
  • Documentation
    • Documentation CenterVideosIndicatorsPropertiesScreener Market data
  • Popular Articles
    • Bull FlagsRelative StrengthPocket PivotsSupport and ResistanceRSI IndicatorMACD IndicatorPiotroski F-scoreSqueeze PlaysWeinsteinTechnical Breakout SetupsTrading TipsPremarket MoversGap Up StocksBest Dividend StocksBullish Engulfing PatternAscending Triangle PatternSwing TradingAll articles ...
  • Subscriptions
  • Account
  • Disclaimer
AffiliatePrivacy
Logo image of AZRX

Azurrx Biopharma Inc (AZRX) Stock News

NASDAQ:AZRX -

3.45
+0.07 (+2.07%)
Last: 9/21/2021, 8:00:01 PM
3.42
-0.03 (-0.87%)
After Hours: 9/21/2021, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News

AZRX Latest News, Press Relases and Analysis

All
Press Releases
4 years ago - By: Benzinga - Mentions: ISEE IVA RLYB BLUE ...
News Image

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs

4 years ago - By: Benzinga - Mentions: LYEL SNOA AMGN KROS ...
News Image

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data

4 years ago - By: PennyStocks.com - Mentions: ABEV SB
News Image

3 Penny Stocks That Top Investors Buying Right Now

4 years ago - By: PennyStocks.com - Mentions: CEI CSCW
News Image

3 Penny Stocks That Top Investors Are Buying Right Now

4 years ago - By: InvestorPlace
News Image

AZRX Stock: The Huge Trial News Lifting Little-Known AzurRX BioPharma Today